Yeungnam Univ J Med.  2009 Dec;26(2):125-129. 10.12701/yujm.2009.26.2.125.

A Case of Colchicine-Induced Neutropenia in Liver Cirrhosis Patient

Affiliations
  • 1Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, Korea. hjlee@med.yu.ac.kr

Abstract

Colchicine is an alkaloid that has been used for treating acute gouty arthritis, psoriasis, scleroderma and Behcet's syndrome. Colchicine decreased liver fibrosis in rats with carbon tetrachloride induced cirrhosis and in patients with many liver diseases. Therapeutic oral doses of colchicine may cause nausea, vomiting, abdominal pain and diarrhea. The adverse effect of colchicine associated with the dose is bone marrow suppression, and especially neutopenia. Neutropenia has often been reported in patients have taken an overdose of colchicine. We describe a 64-year-old female liver cirrhosis patient with neutropenia that was induced by a therapeutic dose of colchicine.

Keyword

Colchicine; Adverse effect; Liver cirrhosis; Neutropenia

MeSH Terms

Abdominal Pain
Animals
Arthritis, Gouty
Behcet Syndrome
Bone Marrow
Carbon Tetrachloride
Colchicine
Diarrhea
Female
Fibrosis
Humans
Liver
Liver Cirrhosis
Liver Diseases
Middle Aged
Nausea
Neutropenia
Psoriasis
Rats
Vomiting
Carbon Tetrachloride
Colchicine
Full Text Links
  • YUJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr